semaglutide and diverticulosis Ozempic Diverticulitis: Exploring the Possible Link semaglutide and diverticulitis Diverticulitis: Management

Still, as mentioned, plenty of people with PCOS have overlap with conditions GLP-1s are approved for, namely diabetes or obesity

Sodium Intake and Hypertension

Wegovy is directly shipped to your house

placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes